Expression of VEGF and MMP-9 in lung cancer
XU Jian-zhon
Abstract
XU Jian-zhon
Abstract
Objective:To detect the relationship between VEGF and MMP-9 and investigate the mechanisms of VEGF effecting invasion of lung cancer. Methods:Immunohistochemistry was used to examine the expression of VEGF ,MMP-9 and iMVD in 45 resected specimens of lung cancer. The relationship between the expression levels of either VEGF or MMP-9 and clinicopathological factors was evaluated. Results:No statistical significant difference was observed between expression of either VEGF or MMP-9 and tumor diameter,lymph node metastasis,pathological stage and type (P0.05).iMVD was 31.36±11.91 per high-power field in VEGF-negative tumors and 45.58±15.60 per high-power field in VEGF-positive tumors,there was a statistical significant difference between them (P0.05). iMVD in MMP-9-positive tumors (44.64±16.41 per high-power field ) was significantly higher than that in MMP-9-negative tumors (31.13±9.41 per high-power field) (P0.05).The expression of VEGF and MMP-9 was significantly associated (C=0.471,P0.001).Conclusions:There is a close correlation between VEGF and MMP-9 expression in lung cancer tissues,and between either VEGF or MMP-9 and iMVD. Both VEGF and MMP-9 possibly take part in the angiogenesis of tumor and promote lung cancer cell infiltration and metastasis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To detect the relationship between VEGF and MMP-9 and investigate the mechanisms of VEGF effecting invasion of lung cancer. Methods:Immunohistochemistry was used to examine the expression of VEGF ,MMP-9 and iMVD in 45 resected specimens of lung cancer. The relationship between the expression levels of either VEGF or MMP-9 and clinicopathological factors was evaluated. Results:No statistical significant difference was observed between expression of either VEGF or MMP-9 and tumor diameter,lymph node metastasis,pathological stage and type (P0.05).iMVD was 31.36±11.91 per high-power field in VEGF-negative tumors and 45.58±15.60 per high-power field in VEGF-positive tumors,there was a statistical significant difference between them (P0.05). iMVD in MMP-9-positive tumors (44.64±16.41 per high-power field ) was significantly higher than that in MMP-9-negative tumors (31.13±9.41 per high-power field) (P0.05).The expression of VEGF and MMP-9 was significantly associated (C=0.471,P0.001).Conclusions:There is a close correlation between VEGF and MMP-9 expression in lung cancer tissues,and between either VEGF or MMP-9 and iMVD. Both VEGF and MMP-9 possibly take part in the angiogenesis of tumor and promote lung cancer cell infiltration and metastasis.
Key concepts: Medicine, Angiogenesis, Lung cancer, Immunohistochemistry, Pathology, Metastasis, VEGF receptors, Pathological